(C) Daily Kos
This story was originally published by Daily Kos and is unaltered.
. . . . . . . . . .
Diabetes News, Mostly from Bluesky [1]
['This Content Is Not Subject To Review Daily Kos Staff Prior To Publication.']
Date: 2025-02-26
I told you last week about making a Bluesky List of the best sources on real diabetes research. Today we get the full use of that list, as you can see below. A simple search on “diabetes” continues to reveal the nastiest denialism and obstruction from the current maladministration, along with a lot of personal accounts of diabetes sufferers.
Rachel Maddow and Lawrence O’Donnell were kvelling last night over how wonderful Bluesky is. Lawrence says that he posts things on Bluesky so the he can find them again in his profile. I, of course, make Lists and Feeds so that everything I want to find again is right there. So yesterday I turned my Diabetes Research List into a Feed. Not everything there is appropriate for this DK story series, but the hit rate is quite high, much better than basic Google searching.
I repeat,
@diabeteschat.bsky.social
@easdnews.bsky.social
@diabresearch-dzd.bsky.social
@thelancetendo.bsky.social
@ucsfdc.bsky.social
Real News
x Youth with type 1 diabetes benefited from continuous glucose monitors regardless of prior blood glucose monitoring frequency, improving their HbA1c levels. by Chan J, Jackson N (...) Everett E et 5 al. in Diabetes Care #MedSky 📖 read the article:
[image or embed] — STITCHES Medicine - the Best of Medical Research (@medicine.stitches.today) February 23, 2025 at 2:31 AM
Well, golleee! What a surprise! But you have to try to falsify the obvious at every stage in real research.
x 🚨Diabetic Gastroenteropathy impacts the entire gastrointestinal tract, complicating assessment & management in diabetes care via @diabetologiajnl.bsky.social. Learn more 👉 link.springer.com/article/10.1... #Diabetes #StenoNord 🔓
[image or embed] — European Association for the Study of Diabetes (@easdnews.bsky.social) February 24, 2025 at 5:46 AM
x Most #diabetes guidelines focus on improving glycaemia through addition of medications, but few address strategies to reduce medication burden for #older adults—a concept known as #deprescribing thelancet.com/journals/lan...
#T1D #T2D #olderadults
#FREE to read w/reg (also FREE)
[image or embed] — The Lancet Diabetes & Endocrinology (@thelancetendo.bsky.social) February 23, 2025 at 5:31 AM
x 🚀Ready to advance your career in #diabetes #research?
#EFSD/@novo-nordisk.bsky.social Future Leaders Award Programme offers: ✅ Up to DKK 5M (~€670,000) over 5 yrs
✅ For scientists & clinicians (7-12 yrs post-PhD/MD)
✅ Deadline: 18.03.2025 Apply 👉 www.europeandiabetesfoundation.org/workshops/10...
[image or embed] — European Association for the Study of Diabetes (@easdnews.bsky.social) February 20, 2025 at 4:59 AM
x 📊A recent phase III trial shows superior #glycaemic control with #IcoSema vs #Semaglutide. “IcoSema provides a good balance between efficacy and safety while also reducing the total number of injections in a year,” the study authors write. 📰Read more👉 easd-elearning.eu/index.html@p... #Diabetes
[image or embed] — European Association for the Study of Diabetes (@easdnews.bsky.social) February 19, 2025 at 6:06 AM
IcoSema is a once-weekly subcutaneous fixed-ratio combination of insulin icodec and semaglutide. It is currently in phase III clinical development.
x 🚨Save the Date!🚨
We are delighted to announce that #EASD2027 will take place in #Budapest, Hungary, from 20 - 24 Sep 2027.🎉
After 25 years, we are excited to return to this vibrant capital to welcome the global #diabetes community.
Stay tuned for more!
#diabetesresearch
[image or embed] — European Association for the Study of Diabetes (@easdnews.bsky.social) February 17, 2025 at 6:57 AM
Denial and Obstruction
x Medicaid is my patients getting regular mammograms instead of advanced breast cancer. It's my patients managing their diabetes instead of going blind. It's people being able to be productive members of society so they can climb out of poverty. Congress is hearing the message: Don't Cut Our Medicaid! — Alice T. Chen, MD (@dralicechen.bsky.social) February 25, 2025 at 12:52 PM
Bluesky, can’t embed. Minnesota Star Tribune, paywalled.
From Opinion: Why are Republican states trying to overturn a pillar of disability rights?
They may not be successful in repealing Section 504 as part of the attack on treating gender dysphoria, but it begs the question of what they might come for next.
x @rweingarten.bsky.social: How’d we get to the point where we have to say that fighting cancer and diabetes and Alzheimer’s isn’t a partisan fight? All this is, is just cruel - and it’s intended to make us stop fighting. But we’re not gonna stop fighting. @AFTHigherEd.bsky.social @aaup.bsky.social
[image or embed] — AFT (@aftunion.bsky.social) February 25, 2025 at 1:04 PM
x Workers started getting their jobs reinstated about four hours after our Friday story detailing the work some of the FDA medical device experts. The work includes reviewing reports of hospitalizations & death re: people who use complex diabetes-control devices. www.nytimes.com/2025/02/24/s...
[image or embed] — Christina Jewett (@by-cjewett.bsky.social) February 24, 2025 at 12:18 PM
[END]
---
[1] Url:
https://www.dailykos.com/stories/2025/2/26/2306300/-Diabetes-News?pm_campaign=front_page&pm_source=more_community&pm_medium=web
Published and (C) by Daily Kos
Content appears here under this condition or license: Site content may be used for any purpose without permission unless otherwise specified.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/dailykos/
